To investigate the potential anti-in¯ammatory eects of sesame oil, which is present in the injectable gold preparation Auromyose 1 , the synthesis of tumour necrosis factor alpha (TNF-a), prostaglandin E 2 (PGE 2 ) and leukotriene B 4 (LTB 4 ) by in vitro stimulated blood cells was measured before, during and after 12 weeks of dietary supplementation with 18 g of sesame oil daily in 11 healthy male volunteers. Neither TNF-a, PGE 2 nor LTB 4 production levels showed statistically signi®cant changes during the 12 weeks of dietary supplementation with sesame oil. These results do not suggest an anti-in¯ammatory eect of sesame oil as present in injectable gold preparations which are used in the treatment of rheumatoid arthritis.
CHRYSOTHERAPY for rheumatoid arthritis (RA) [1] has been applied in many dierent preparations during the past 60 yr. Gold salts, such as aurothiomalate and aurothioglucose, have been given in both oily suspensions and aqueous solutions. Oily suspensions were associated with reduced toxicity [2] and enhanced ecacy as compared to aqueous solutions [3] . Since oily suspensions produced more even serum gold concentrations, it was assumed that the depot function of the oil was responsible for the favourable ecacy/toxicity balance of oily suspensions compared with aqueous solutions. However, the therapeutic response is not related to serum gold levels [4] . Therefore, the dierence in ecacy between aqueous solutions and oily suspensions must have another explanation.
With the increasing evidence that dietary supplementation of particular fatty acids may have antiin¯ammatory and immunomodulating eects [5] , the hypothesis arose that the oil in i.m. gold injections might play a role in the enhanced ecacy of these preparations. Polyunsaturated fatty acids (PUFAs) are precursors for the synthesis of eicosanoids, which include prostaglandins, thromboxanes, prostacyclins and leukotrienes. Eicosanoids play an essential role in the in¯ammatory process [6, 7] and are, therefore, targets for pharmacological intervention in in¯am-matory joint disease.
Modulation of eicosanoid precursor fatty acids by dietary supplementation with ®sh oil, borage seed oil or blackcurrant seed oil has been shown to decrease the production of prostaglandin E 2 (PGE 2 ), leukotriene B 4 (LTB 4 ) [8±13] and the in¯ammatory cytokines tumour necrosis factor alpha (TNF-a) and interleukin-1 (IL-1) [13, 14] . Furthermore, a suppressive eect of essential fatty acids on lymphocyte and synovial cell proliferation in vitro [15±18], and acute and chronic in¯ammation in animal models [19±21] , has been observed. Clinical improvement of RA patients was reported during dietary supplementation with ®sh oil [8±10, 22, 23] , evening primrose oil [24, 25] , borage seed oil [26] , blackcurrant seed oil [27] and olive oil [28] .
The present pilot study was undertaken to investigate whether sesame oil, which is present in the injectable gold preparation Auromyose 1 , had an anti-in¯ammatory eect. Therefore, in healthy volunteers, the eect of dietary supplementation with sesame oil on the production of PGE 2 , LTB 4 and TNF-a by in vitro stimulated blood cells was investigated.
SUBJECTS AND METHODS

Subjects and study design
The study was approved by the committee of medical ethics of the University Hospital Leiden. Eleven healthy male volunteers entered the study in January 1993 after giving informed consent (average age 28 yr; range 18±50). The subjects were free of disease and refrained from taking medication during the study.
For 12 weeks, the subjects added daily 18 g of sesame oil to their otherwise unchanged diets. Sesame oil was prepared by the hospital pharmacy as a 400 mg/ml emulsion containing the following substances: sesame oil, water, methylcellulose as emulsifying agent (0.8% g/v), saccharin sodium, citric acid and banana essence as¯avouring agents, and benzoic acid as preservative. The volunteers had to take 45 ml of this emulsion daily. Sesame oil is known by gas chromatography to have the following fatty acid composition: <0.5% saturated fatty acids, 7±12% palmitic acid (C16:0), 4±6% stearic acid (C18:0), 35±50% oleic acid (C18:1), 35±50% linolenic acid (C18:2), <1% linolenic acid including gamma linolenic acid (GLA; C18:3, n-6) and <1% arachidic acid (C20:0) (European pharmacopoeia, 2nd edn).
Before and after supplementation with sesame oil, subjects were interviewed by a dietician (GS) to estimate their mean daily energy intake and the daily intake of PUFAs. Their body weight was also measured.
The production of TNF-a, PGE 2 and LTB 4 by in vitro stimulated blood cells was assessed at ®ve time points in the study: before the start of sesame oil supplementation, during supplementation at 6 and 12 weeks, and during the wash-out period at 10 and 20 weeks after the end of the supplementation. To ascertain reproducibility, blood samples were obtained on three dierent days in 1 week during each of the ®ve study phases. The mean of these three determinations was calculated and used for further analysis.
Stimulation of whole blood in vitro
Venous blood (10 ml) was drawn into heparinized tubes (Becton Dickinson, UK), which were kept at room temperature and used within 3 h. Another 4 ml of venous blood were collected in tubes containing EDTA for total and dierential leucocyte counts.
Heparinized samples were diluted 10-fold with RPMI 1640 (Gibco, Eggenstein, Germany), supplemented with antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin; Boehringer Mannheim, Germany), and aliquoted in 24-well plates (Costar 3524, Cambridge, MA, USA).
For stimulation of TNF-a production in whole blood cultures, 10 mg/ml lipopolysaccharide (Sigma, St Louis, MO, USA) was added to the wells (®nal volume 1 ml/well). Thereafter, the plates were incubated for 24 h at 378C in a humidi®ed atmosphere with 5% CO 2 . After incubation, the cell-free supernatants were removed and stored at À208C until required.
For the induction of PGE 2 and LTB 4 production by whole blood cultures, plates were pre-incubated at 378C, whereafter 20 mM calcium ionophore A23187 (Sigma) was added to the wells and the plates were incubated for 30 min at 378C in a humi®ed atmosphere with 5% CO 2 . Supernatants were harvested and stored at À708C.
Determination of TNF-a, PGE 2 and LTB 4 TNF-a was measured by ELISA as described previously [29] . Levels of PGE 2 in the culture supernatants were determined by radioimmunoassay as described previously [30] . LTB 4 was measured by a radioimmunoassay from Amersham, Hertogenbosch, The Netherlands, according to the manufacturer's instructions.
Statistical analysis
The dierences in the production of TNF-a, PGE 2 or LTB 4 between baseline and 6 or 12 weeks of dietary supplementation with sesame oil, between baseline and 10 or 20 weeks of wash-out, and between the end of supplementation (12 weeks) and 10 or 20 weeks of wash-out, were analysed using the paired Student's t-test or Wilcoxon's signed rank test. P values <0.05 were considered to be signi®cant.
RESULTS
All 11 healthy male volunteers completed the protocol. Their normal diets did not change during the study. The estimated mean daily energy intake was 2600 kcal. Fatty acids were responsible for 33% of this energy intake and the estimated mean daily intake of PUFAs was 15 g. Furthermore, the mean body weight of 76 kg did not increase during the dietary supplementation with sesame oil. Total and dierential leucocyte counts were in the normal range in all subjects during the study. None of the volunteers reported adverse events from the sesame oil emulsion.
The mean production of TNF-a, PGE 2 and LTB 4 by in vitro stimulated whole blood cultures were calculated for the ®ve study points (Table I) . None of the dierences between baseline and 6 or 12 weeks of dietary supplementation with sesame oil reached statistical signi®cance. Comparison of the production at the end of 12 weeks dietary supplementation with that after 10 or 20 weeks of wash-out did not show any signi®cant dierences either. During the washout period, the production levels of TNF-a and PGE 2 were not signi®cantly dierent from their baseline production levels. LTB 4 production, on the other hand, was signi®cantly decreased after 10 weeks of wash-out as compared to baseline production (P = 0.04). Data expressed as the mean2 S.E.M. *P < 0.05 as compared to baseline using Wilcoxon's signed rank test for paired samples.
TEN WOLDE ET AL.: SESAME OIL IN INJECTABLE GOLD DISCUSSION The main conclusion of this pilot study is that neither TNF-a production nor eicosanoid production by in vitro stimulated whole blood cultures was signi®cantly decreased during 12 weeks of dietary supplementation with sesame oil.
Anti-in¯ammatory eects in vitro and in vivo have been most consistently reported for plant seed oils containing relatively large amounts of GLA, such as evening primrose oil and blackcurrant seed oil [13, 15, 21, 24, 26, 27, 31±34] . This eect can be explained by the fact that metabolism of GLA results in increased production of PGE 1 , an eicosanoid with anti-in¯ammatory properties [5, 31, 35] . Sesame oil contains <1% GLA, which might explain the lack of a signi®cant eect of dietary supplementation with sesame oil on the eicosanoid synthesis.
On the other hand, sesame oil is rich in PUFAs other than GLA and is known to inhibit tumour cell line growth in vitro [36, 37] . Moreover, several studies have suggested that PUFAs can modulate immune responses by acting directly on T cells [13, 16, 17] . We observed a non-signi®cant declining trend in TNF-a production during dietary supplementation with sesame oil and a restoring trend during the wash-out period. This might suggest a direct eect of sesame oil on T lymphocytes and monocytes. Since TNF-a is a critical in¯ammatory mediator in RA, it is an important target for speci®c immunotherapy.
For this pilot study, we preferred oral administration of sesame oil in healthy volunteers. We are aware that results in healthy volunteers cannot be extrapolated to RA patients, although an earlier study has shown that the eect of another plant seed oil on cytokine and prostaglandin production by monocytes was not essentially dierent between RA patients and healthy volunteers [13] . Furthermore, the dosage of sesame oil in the present study was much higher than that RA patients will receive with i.m. gold injections. The diets were supplemented with 18 g of sesame oil daily, of which at least 10% will be absorbed. The usual weekly dose of i.m. gold is 50 mg of gold in 0.25 ml of oil. The amount of sesame oil in 0.25 ml of injectable gold (Auromyose 1 ) is H225 mg. Therefore, it can be concluded that even if there is a weak eect of high-dose sesame oil on TNF-a or LTB 4 production, the dose of sesame oil that is present in gold injections will probably not have an anti-in¯ammatory eect in RA patients. In the future, it would be interesting to investigate the ecacy of i.m. gold preparations containing GLA-rich plant seed oils or ®sh oil.
